Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenylcapsaicin is a synthetic analog of capsaicin, the active compound in chili peppers. It is designed to have higher bioavailability and stability compared to natural capsaicin[1][8]. Phenylcapsaicin acts as an agonist of the transient receptor potential vanilloid 1 (TRPV1) receptor, also known as the "capsaicin receptor," which plays roles in pain perception, thermoregulation, and metabolic processes[2][6][7]. Research indicates that phenylcapsaicin can enhance fat oxidation during aerobic exercise, improve strength performance, reduce muscle damage and perceived exertion during resistance training, and may support weight management by increasing metabolism and reducing energy intake[1][3][4][6]. Additionally, it has been shown to lower serum zonulin levels—suggesting improved gut barrier function—and inhibit bacterial quorum sensing in the gut microbiome[6][8]. The primary developer and manufacturer is aXichem; its commercial product name is aXivite[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenylcapsaicin.